Familial partial lipodystrophy syndromes are rare diseases characterized by variable loss of ad ipose tissue and metabolic comorbidities occur ring during childhood or adolescence. The dis crimination between different FLPD syndromes is frequently challenging as they often demon strate similar anthropometric, clinical, and met abolic characteristics. The patient presented in this image is characterized by a loss of adipose tis sue in the lower extremity with remarkably well defined muscles especially of the calves / gluteal region, mostly excessive amounts of subcutane ous abdominal and truncal fat, as well as edema tous and round face, feigning cushingoid appear ance. 1,2 Because of the onset of fat transformation which occurred during childhood and the nega tive screening for type 2 FPLD, we suggest type 1 FPLD, Köbberling syndrome, to be present in this woman. Köbberling syndrome, is an autoso mal dominant inherited orphan disease which is rarely diagnosed; however, higher incidence rates than are actually reported can be assumed. So far, these clinical features have only been observed in women. In contrast to other forms of FPLD such as type 2 FPLD (Dunnigan disease, LMNA gene) or type 3 FPLD (PPAR -γ gene), to date, no patho genetic mutations have been identified. A strong predictor for Köbberling syndrome is the ratio of truncal fat weight (in kilograms) to fat weight of the lower limbs which was almost 5 in this patient (cutoff value, 2.153) 1 assessed by dual energy X ray absorptiometry. Most patients are affect ed by impairments in glucose and lipid metabo lism as well as fatty liver disease, increasing their risk of cardiovascular disease. 3 It is assumed that such patients should be thoroughly diagnosed and an early initiation of intensive treatment of relat ed comorbidities is recommended. Evidence sug gests that patients with type 1 FPLD might ben efit from bariatric surgery in terms of metabolic abnormalities and on cosmetic grounds. 4
We report the case of a 49 year old woman with long standing type 2 diabetes (mean glycated he moglobin about 10% [86 mmol/mol] over the past years) that was never sufficiently controlled, intol erance against multiple antidiabetic agents (met formin, pioglitazone, glucagon like peptide 1 re ceptor agonists), enormous daily insulin require ments (>300 insulin units), and high C peptide levels (3.15; normal range 0.78-1.89 ng/ml), in dicating marked insulin resistance. Comorbidi ties included morbid obesity, significant hypertri glyceridemia, low levels of high density lipopro tein, arterial hypertension, and hepatic steatosis.
The patient's body measurements were as follows: body weight of 137 kg and a height of 164 cm (body mass index, 49.1 kg/m²), total body fat 40.3%. Upon clinical examination, the woman presented with suspicious absence of subcutane ous adipose tissue at the lower extremities and gluteal region, feigning muscular appearance. In contrast adipose tissue in the abdominal region and trunk was well developed and excess fat was observed in the face, chin, and neck, resembling cushingoid appearance, while striae rubrae, skin atrophy, or muscle weakness were not present (FIGURE 1A-1C) .
The onset of the physical transformation oc curred when the patient was 3 years old. Similar physical features and metabolic alterations were reported in her mother and grandmother. In con trast, all of her male first degree relatives were lean and metabolically healthy (FIGURE 1D-1G) . En docrine diseases such as endogenous hypercor tisolism, polycystic ovary syndrome, or hypothy roidism had been ruled out. Genetic testing ex cluded defects in the LMNA gene, which is asso ciated with type 2 familial partial lipodystrophy (FPLD), Dunnigan disease.
After considering the metabolic impairments and the clinical features which were also present in female family members, we suspected type 1 FPLD, Köbberling syndrome, to be present in this woman. 
